Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 4Phase 1/2 2Phase 1 2

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Lymphoid 1Gynecologic 1

Conditions

Breast Neoplasms 222Carcinoma, Non-Small-Cell Lung 219Prostatic Neoplasms 156Multiple Myeloma 142Neoplasms 133Colorectal Neoplasms 118Leukemia, Myeloid, Acute 110Lung Neoplasms 103Neoplasm Metastasis 96Squamous Cell Carcinoma of Head and Neck 91Carcinoma, Hepatocellular 86Lymphoma 81Melanoma 78Pancreatic Neoplasms 74Triple Negative Breast Neoplasms 72Ovarian Neoplasms 66Sarcoma 65Lymphoma, Large B-Cell, Diffuse 61Carcinoma, Renal Cell 61Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Head and Neck Neoplasms 57Recurrence 56Lymphoma, Non-Hodgkin 55Stomach Neoplasms 53Leukemia, Lymphocytic, Chronic, B-Cell 52Hematologic Neoplasms 52Endometrial Neoplasms 50Small Cell Lung Carcinoma 48Urinary Bladder Neoplasms 46

Interventions

liposomal doxorubicin 1dehydroftorafur 1Zidovudine 1Vincristine 1Valganciclovir 1Specimen Handling 1Sirolimus 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Rituximab 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1Prednisone 1Nivolumab 1Mitozytrex 1Mitomycin 1Magnetic Resonance Spectroscopy 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Fluorodeoxyglucose F18 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Colonoscopy 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × HIV Infections × 90 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT07545746 2026-06-02

ASCEND

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT02437851 2026-04-20

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

AIDS Malignancy Consortium

Phase 2 Completed
16 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡